BioNexus Gene Lab Corp. Increase (Decrease) in Inventories
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) in Inventories of -$9.55 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-05-15
- BioNexus Gene Lab Corp. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$9.55K.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$330.75K.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$208.18K, a 158.46% decline year-over-year.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for the quarter ending 2025-06-30 was $36.48K.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for fiscal 2025 was -$711.92K, a 383.80% decline from fiscal 2024.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for fiscal 2024 was $250.85K.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for fiscal 2023 was -$160.39K, a 129.48% decline from fiscal 2022.
- BioNexus Gene Lab Corp. increase (decrease) in inventories for fiscal 2022 was $544.11K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$9.55K 10-Q · filed 2026-05-15 | -$340.29K derived: sum of 2 quarters · filed 2026-05-15 | -$548.47K derived: sum of 3 quarters · filed 2026-05-15 | -$511.99K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | -$330.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | -$538.92K derived: sum of 2 quarters · filed 2026-04-14 | -$502.44K derived: sum of 3 quarters · filed 2026-04-14 | -$711.92K 10-K · filed 2026-04-14 | |||
| 2025-09-30 | -$208.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$171.70K derived: sum of 2 quarters · filed 2025-11-14 | -$381.18K 10-Q · filed 2025-11-14 | -$381.63K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $36.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$173.00K 10-Q · filed 2025-08-18 | -$173.45K derived: sum of 3 quarters · filed 2026-05-15 | $182.62K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-03-31 | -$209.48K 10-Q · filed 2026-05-15 | $209.48K 10-Q · filed 2025-05-15 | -$209.93K derived: sum of 2 quarters · filed 2026-05-15 | $146.14K derived: sum of 3 quarters · filed 2026-05-15 | -$19.44K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$452.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $355.62K derived: sum of 2 quarters · filed 2026-04-14 | $190.04K derived: sum of 3 quarters · filed 2026-04-14 | $250.85K 10-K · filed 2026-04-14 | |||
| 2024-09-30 | $356.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $190.49K derived: sum of 2 quarters · filed 2025-11-14 | $251.31K 10-Q · filed 2025-11-14 | -$39.58K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$165.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$104.77K 10-Q · filed 2025-08-18 | -$395.66K derived: sum of 3 quarters · filed 2025-08-18 | -$453.12K derived: sum of 4 quarters · filed 2025-08-18 | |||
| 2024-03-31 | $60.82K 10-Q · filed 2025-05-15 | -$60.82K 10-Q · filed 2024-05-15 | -$230.07K derived: sum of 2 quarters · filed 2025-05-15 | -$287.54K derived: sum of 3 quarters · filed 2025-05-15 | -$21.40K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$290.89K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$348.35K derived: sum of 2 quarters · filed 2024-11-15 | -$82.22K derived: sum of 3 quarters · filed 2024-11-15 | -$160.39K 10-K · filed 2024-04-16 | |||
| 2023-09-30 | -$57.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-15 | $208.67K derived: sum of 2 quarters · filed 2024-11-15 | $130.50K 10-Q · filed 2024-11-15 | $1.10M derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-06-30 | $266.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $187.97K 10-Q · filed 2024-08-14 | $1.16M derived: sum of 3 quarters · filed 2024-08-14 | $741.79K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$78.17K 10-Q · filed 2024-05-15 | $891.91K derived: sum of 2 quarters · filed 2024-05-15 | $475.65K derived: sum of 3 quarters · filed 2024-05-15 | $338.95K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $970.08K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $553.83K derived: sum of 2 quarters · filed 2024-04-16 | $417.12K derived: sum of 3 quarters · filed 2024-04-16 | $544.11K 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$416.25K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | -$552.96K derived: sum of 2 quarters · filed 2024-03-26 | -$425.97K 10-Q/A · filed 2024-03-26 | $425.97K 10-Q · filed 2022-11-14 | -$460.21K derived: sum of 4 quarters · filed 2024-03-26 | ||
| 2022-06-30 | -$136.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$9.72K 10-Q · filed 2023-08-16 | $9.72K 10-Q · filed 2022-08-15 | -$43.95K derived: sum of 3 quarters · filed 2023-08-16 | $171.50K derived: sum of 4 quarters · filed 2023-08-16 | ||
| 2022-03-31 | $126.99K 10-Q · filed 2023-05-09 | $92.75K derived: sum of 2 quarters · filed 2023-05-09 | $308.21K derived: sum of 3 quarters · filed 2023-05-09 | -$511.78K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$34.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $181.22K derived: sum of 2 quarters · filed 2023-03-31 | -$638.77K derived: sum of 3 quarters · filed 2023-03-31 | -$345.75K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $215.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$604.53K derived: sum of 2 quarters · filed 2022-11-14 | -$311.51K 10-Q · filed 2022-11-14 | -$289.74K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$819.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$526.97K 10-Q · filed 2022-08-15 | -$505.19K derived: sum of 3 quarters · filed 2022-08-15 | -$351.66K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $293.02K 10-Q · filed 2022-05-16 | -$293.02K 10-Q · filed 2021-05-18 | $314.79K derived: sum of 2 quarters · filed 2022-05-16 | $468.33K derived: sum of 3 quarters · filed 2022-05-16 | $438.80K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $21.77K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $175.30K derived: sum of 2 quarters · filed 2022-04-06 | $145.78K derived: sum of 3 quarters · filed 2022-04-06 | $147.04K 10-K · filed 2022-04-06 | |||
| 2020-09-30 | $153.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $124.01K derived: sum of 2 quarters · filed 2021-11-15 | $125.27K 10-Q · filed 2021-11-15 | -$11.59K 10-Q · filed 2020-11-03 | $129.50K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$29.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$28.27K 10-Q · filed 2021-08-12 | -$13.52K 10-Q · filed 2020-08-11 | -$24.03K derived: sum of 3 quarters · filed 2021-08-12 | -$29.91K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $1.26K 10-Q · filed 2021-05-18 | $5.50K derived: sum of 2 quarters · filed 2021-05-18 | -$381.00 derived: sum of 3 quarters · filed 2021-05-18 | $3.73K derived: sum of 4 quarters · filed 2021-05-18 | |||
| 2019-12-31 | $4.24K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | -$1.64K derived: sum of 2 quarters · filed 2021-03-30 | $2.47K derived: sum of 3 quarters · filed 2021-03-30 | $7.72K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | -$5.88K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.77K derived: sum of 2 quarters · filed 2020-11-09 | $3.48K 10-Q/A · filed 2020-11-09 | $9.09K derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $4.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $9.36K 10-Q · filed 2020-08-11 | $14.96K derived: sum of 3 quarters · filed 2020-08-11 | $17.77K derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | $5.25K 10-Q · filed 2020-05-08 | $10.85K derived: sum of 2 quarters · filed 2020-05-08 | $13.66K derived: sum of 3 quarters · filed 2020-05-08 | $31.46K derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | $5.60K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $8.41K derived: sum of 2 quarters · filed 2020-03-31 | $26.21K derived: sum of 3 quarters · filed 2020-03-31 | $16.79K 10-K · filed 2020-03-31 | |||
| 2018-09-30 | $2.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $20.61K derived: sum of 2 quarters · filed 2019-11-14 | $11.18K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $17.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.38K 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | -$9.42K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |